Patients With Advanced Refractory Solid Tumors clinical trials

Explore recruiting patients with advanced refractory solid tumors clinical trials.

Recruiting patients with advanced refractory solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Advanced Refractory Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

FIRST IN HUMAN PHASE 1 DOSE ESCALATION AND EXPANSION CLINICAL TRIAL TO EVALUATE THE SAFETY, PHARMACOKINETICS AND ANTITUMOR ACTIVITY OF INTRAVENOUS AROG4-01 IN PATIENTS WITH ADVANCED SOLID TUMORS.

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Patients With Advanced Refractory Solid Tumors trials by city

Patients With Advanced Refractory Solid Tumors in Toronto Patients With Advanced Refractory Solid Tumors in Vancouver Patients With Advanced Refractory Solid Tumors in Montreal Patients With Advanced Refractory Solid Tumors in Calgary Patients With Advanced Refractory Solid Tumors in Edmonton Patients With Advanced Refractory Solid Tumors in Ottawa Patients With Advanced Refractory Solid Tumors in Winnipeg Patients With Advanced Refractory Solid Tumors in Quebec City Patients With Advanced Refractory Solid Tumors in Hamilton Patients With Advanced Refractory Solid Tumors in Kitchener Patients With Advanced Refractory Solid Tumors in London Patients With Advanced Refractory Solid Tumors in Halifax Patients With Advanced Refractory Solid Tumors in New York Patients With Advanced Refractory Solid Tumors in Los Angeles Patients With Advanced Refractory Solid Tumors in Chicago Patients With Advanced Refractory Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease